Opportunity Analysis
See What's Changed Since Your Target List Was Built
Send us the lists your teams are using today. In weeks, ODAIA scores every HCP based on current value and predicted opportunity. No rebuild, no new frameworks, just a fresh view of where to focus your field and digital efforts today.
Trusted by innovative biopharmas
The Problem
Your HCP list was right when you built it. But your opportunity kept moving.
A target list reflects the priorities and information available when it was built. But HCP opportunity continues to change as new patient, prescribing and market signals emerge
Today's best opportunity may not be on the list.
Patients start therapy. Prescribers switch. Referral patterns shift. An HCP who wasn't worth a call in Q1 can be your highest-value target by Q3, and nothing flags it.
Your list stays fixed while opportunity changes.
The next refresh may be two or three quarters out. Until then reps keep calling the same names and marketing keeps spending against the same audience.
Resources prioritize the list, not the opportunity
Resources stay pointed at HCPs whose value has faded, while emerging prescribers never make the cut. The strategy was never wrong. The HCPs changed.
Send us your existing data. Our team runs the analysis and delivers your results in 2–4 weeks. No software deployment or IT project required
Step 1
Send your lists
Your existing segmentation and targeting lists, Rx and claims data, and territory mapping. No integration or new infrastructure required.
Step 2
We re-score every HCP
ODAIA scores each HCP on current value and predicted opportunity, then compares those scores with how your lists rank them today.
Step 3
You get the analysis
A refreshed list you can action, a side-by-side comparison showing where the two views disagree, and named HCP examples explaining what changed and why.
What lands in your inbox
A refreshed score for every HCP, delivered as a CSV your ops team can use immediately
A side-by-side comparison showing where ODAIA ranks HCPs higher, lower, or in line with your list
A breakdown of the movement, with specific HCP stories behind the shifts
Who it's for
Anyone who wants to pressure-test the assumptions behind their current segmentation
Teams who believe dynamic targeting is the right direction but don't have full buy-in yet
Brand and commercial teams who want proof of impact before committing to a platform
What we're seeing across brands
Across engagements spanning from emerging biotech to Top 10 pharma, comparing ODAIA's scores against lists refreshed just 3–4 months earlier.
53%
of HCPs Change in Priority
Three months after a list refresh, 53% of HCPs have changed value. The other 47% score in line with your list. This isn't a case for starting over, it's a precise read on what moved.
31%
Scored Higher
These HCPs have taken actions that make them more valuable to your brand than your current list reflects.
These are the calls your team isn't making yet.
These are the calls your team isn't making yet.
22%
Scored Lower
Engagement or impact has fallen off since the list was built. Resources pointed here can move elsewhere.
These are resources that can be redirected.
These are resources that can be redirected.
Get Started
See what's changed — and where you may be missing opportunity
Grab time with our team to talk through your brand, your objectives, how you're targeting today, and the data you already have. If it makes sense, we'll scope next steps out together.
$53B+
Revenue supported
+14%
Increase in brand reach
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Worth a look
Featured Resources
Dynamic Targeting GuideDiscover how pharma teams are moving beyond static lists.Read Guide →AI Readiness AssessmentFind out where your commercial org stands.Download Checklist →Case StudiesDiscover how top pharma teams are using ODAIA.Learn More →Demo Video LibraryBrowse our demo videos to see ODAIA in action.Watch Now →